According to Luo Xin Pharmaceutical's announcement, an inquiry on August 6 revealed that in total, some of the shares held by shareholders Deyi Chengdu, Deyi Health, and Desheng Health were judicially frozen. A total of 924,1258 shares were frozen, accounting for 15.74% of their shares and 0.85% of the company's total share capital. The average date of freezing was August 5, and the expiration date was June 15, 2029. The shareholders mentioned above are not the company's largest shareholders, etc. The freeze will not have a significant impact on corporate governance, daily operations, and control, but it has been enforced or passively reduced, and the company will continue to monitor and disclose progress.

According to Luo Xin Pharmaceutical's announcement, an inquiry on August 6 revealed that in total, some of the shares held by shareholders Deyi Chengdu, Deyi Health, and Desheng Health were judicially frozen. A total of 924,1258 shares were frozen, accounting for 15.74% of their shares and 0.85% of the company's total share capital. The average date of freezing was August 5, and the expiration date was June 15, 2029. The shareholders mentioned above are not the company's largest shareholders, etc. The freeze will not have a significant impact on corporate governance, daily operations, and control, but it has been enforced or passively reduced, and the company will continue to monitor and disclose progress.